TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
7,374
|
31,805
|
14,172 |
Financial expenses |
35
|
38
|
11 |
Earnings before taxes |
-1,972
|
5,679
|
45 |
EBITDA |
-1,843
|
5,813
|
165 |
Total assets |
11,429
|
14,218
|
19,280 |
Current assets |
8,753
|
13,728
|
19,258 |
Current liabilities |
1,627
|
2,392
|
12,716 |
Equity capital |
9,480
|
11,171
|
6,564 |
- share capital |
500
![]() |
500
![]() |
500 |
Employees (average) |
5
![]() |
5
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.9%
|
78.6%
|
34.0% |
Turnover per employee |
1,475
|
6,361
|
2,362 |
Profit as a percentage of turnover |
-26.7%
|
17.9%
|
0.3% |
Return on assets (ROA) |
-16.9%
|
40.2%
|
0.3% |
Current ratio |
538.0%
|
573.9%
|
151.4% |
Return on equity (ROE) |
-20.8%
|
50.8%
|
0.7% |
Change turnover |
-24,431
|
17,633
|
-2,682 |
Change turnover % |
-77%
|
124%
|
-16% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-17%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.